Variables

Non-OSA

n = 91

Mild

n = 76

Moderate

n = 57

Severe

n = 76

P-value

Age (years)

41.7 ± 14.0

51.2 ± 11.7

53.4 ± 12.5

55.7 ± 11.2

<0.001*

BMI (kg/m²)

33.9 ± 7.6

35.1 ± 7.0

38.5 ± 8.8

41.2 ± 6.9

<0.001*

HTN

24 (26.4)

22 (28.9)

23 (40.4)

57 (75.0)

0.013*

Severity of HTN¹

(n = 126)

Monotherapy

12 (50.0)

8 (36.4)

6 (26.1)

8 (14.0)

0.037*

2-line therapy

7 (29.2)

8 (36.4)

9 (39.1)

22 (38.6)

≥3-line therapy

5 (20.8)

6 (27.3)

8 (34.8)

27 (47.4)

T2DM

20 (22.0)

24 (31.6)

20 (35.1)

34 (44.7)

0.040*

Severity of T2DM²

(n = 98)

Monotherapy

11 (55.0)

11 (45.8)

5 (25.0)

4 (11.8)

0.017*

2-line therapy

5 (25.0)

7 (29.2)

6 (30.0)

11 (32.4)

≥3-line therapy

4 (20.0)

6 (25.0)

9 (45.0)

19 (55.9)

Sleep efficiency

79.0 ± 14.7

75.1 ± 16.5

71.8 ± 15.8

69.6 ± 17.6

0.022*

AHI (event/H)

3.6 ± 3.3

12.5 ± 8.0

22.0 ± 4.5

54.0 ± 20.1

<0.001*

STOP-BANG score

3.9 ± 1.6

6.2 ± 0.8

6.4 ± 0.8

6.8 ± 0.8

<0.001*

Nadir O₂ sat%

91.7 ± 2.5

87.0 ± 4.3

82.5 ± 7.7

74.9 ± 14.2

<0.001*

HBA1C²

for patients with T2DM

7.1 ± 1.6

8.1 ± 1.5

8.5 ± 1.5

8.7 ± 1.2

0.004*